163 related articles for article (PubMed ID: 35538806)
1. Long-term Effect of Hematopoietic Stem Cell Transplantation on the Quality of Life of Patients with β-thalassemia Major in Guangxi, China - A Cross-sectional Study.
Zhai L; Liu Y; Huo R; Pan Z; Zhang Y; Li Z; Li F; Fan J; Wei W
Curr Stem Cell Res Ther; 2023; 18(3):410-416. PubMed ID: 35538806
[TBL] [Abstract][Full Text] [Related]
2. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients.
Uygun V; Tayfun F; Akcan M; Karasu GT; Kupesiz A; Hazar V; Yeşilipek A
Pediatr Hematol Oncol; 2012 Aug; 29(5):461-71. PubMed ID: 22712884
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life in Patients with β-thalassemia Major: Short-term and Long-term Effects After Haematopoietic Stem Cell Transplantation.
Zhai L; Liu Y; Huo R; Pan Z; Bin J; Li Z; Tang Q; Fan J
Curr Stem Cell Res Ther; 2021; 16(8):924-930. PubMed ID: 33563174
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
[TBL] [Abstract][Full Text] [Related]
5. Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
Sun L; Wang N; Chen Y; Tang L; Xing C; Lu N; Shi Y; Ma Y; Lin F; Yu K; Feng J
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1592-1596. PubMed ID: 30951841
[TBL] [Abstract][Full Text] [Related]
6. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.
Caocci G; Efficace F; Ciotti F; Roncarolo MG; Vacca A; Piras E; Littera R; Dawood Markous RS; Collins GS; Ciceri F; Mandelli F; Marktel S; La Nasa G
Biol Blood Marrow Transplant; 2011 Jun; 17(6):861-6. PubMed ID: 20870029
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
[TBL] [Abstract][Full Text] [Related]
9. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.
La Nasa G; Caocci G; Efficace F; Dessì C; Vacca A; Piras E; Sanna M; Marcias M; Littera R; Carcassi C; Lucarelli G
Blood; 2013 Sep; 122(13):2262-70. PubMed ID: 23958950
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
[TBL] [Abstract][Full Text] [Related]
11. Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.
Gauthier A; Bleyzac N; Garnier N; Kebaili K; Joly P; Goutagny MP; Mollet I; Goutelle S; Renard C; Bertrand Y
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2285-2291. PubMed ID: 32007639
[TBL] [Abstract][Full Text] [Related]
12. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
[TBL] [Abstract][Full Text] [Related]
13. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin.
Park BK; Kim HS; Kim S; Lee JW; Park YS; Jang PS; Chung NG; Jeong DC; Cho B
Blood Res; 2018 Jun; 53(2):145-151. PubMed ID: 29963521
[TBL] [Abstract][Full Text] [Related]
15. Addition of ruxolitinib in Graft-versus-Host disease prophylaxis for pediatric β-Thalassemia major patients after allogeneic stem cell transplantation: A retrospective cohort study.
Hong X; Chen Y; Lu J; Lu Q
Pediatr Transplant; 2023 Mar; 27(2):e14466. PubMed ID: 36597217
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J
Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme.
Wang L; Kong P; Zhang C; Gao L; Zhu L; Liu J; Gao S; Chen T; Liu H; Yao H; Liu Y; Feng Y; Zhao L; Li Y; Gao L; Zhang X
Ann Hematol; 2023 Jun; 102(6):1569-1579. PubMed ID: 37097455
[TBL] [Abstract][Full Text] [Related]
18. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
Kaida K; Ikegame K; Inoue T; Maruyama S; Ishii S; Uchida N; Doki N; Eto T; Fukuda T; Katayama Y; Takada S; Kawakita T; Ichinohe T; Atsuta Y; Daimon T; Ogawa H
Transplant Cell Ther; 2023 Apr; 29(4):273.e1-273.e9. PubMed ID: 36641032
[TBL] [Abstract][Full Text] [Related]
19. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
20. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies].
Wang J; Zhou J; Zheng HF; Wang PF; Fu CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
